US
Altaire Pharmaceuticals recalls OTC products
July 9, 2019Manufacturing and Production Altaire Pharmaceuticals, US, recall, walmart
Aquebogue, New York-based firm Altaire Pharmaceuticals has enacted a voluntary recall of a number of products sold in Walmart and …
Trump says executive order will ensure US will pay lowest prices in the world for drugs
July 8, 2019Sales and Marketing Trump, US, executive order, pharma, politics, pricing
President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United …
FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis
June 27, 2019Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis
Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …
Takeda plans to vacate all 1,000 staff from US HQ by the year’s end
June 26, 2019Manufacturing and Production, Medical Communications, Sales and Marketing Shire, Takeda, US, pharma
Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, Illinois, by the end of …
FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris
June 25, 2019Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma
Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …
MSD’s Keytruda snatches up first approval in small cell lung cancer
June 19, 2019Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma
MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …
FDA advisory panel backs TB Alliance’s tuberculosis regimen
June 10, 2019Sales and Marketing FDA, TB Alliance, US, pharma, tuberculosis
An FDA advisory panel has voted to recommend the investigational drug pretomanid, developed by the non-profit organisation TB Alliance, as …
Donald Trump causes confusion as to whether NHS will be ‘on the table’ in trade deal talks
June 6, 2019Business Services, Medical Communications Donald Trump, NHS, UK, US, healthcare, pharma
President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit …
Healthcare would be ‘on the table’ in post-Brexit trade negotiations with US, Trump’s ambassador says
June 3, 2019Sales and Marketing J&J, JJ, NHS, UK, US, brexit, healthcare
The American Ambassador to the United Kingdom has said that Britain’s healthcare system would be ‘on the table’ in post-Brexit …
GSK to reintroduce bonuses for sales reps
May 24, 2019Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal
British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …
Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says
May 14, 2019Manufacturing and Production China, US, USTR, pharma, tariffs, trade
The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …
FDA to end controversial “alternative summary reporting” of medical devices in bid to boost transparency
May 10, 2019Medical Communications, Research and Development, Sales and Marketing FDA, US, adverse events, medical devices, pharma
The FDA has revealed that it plans to terminate its “alternative summary reporting” programme which has allowed the manufacturers of …
US prescription drugs most expensive in world, analysis shows
May 8, 2019Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs
Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …
FDA approves first two drugs for transthyretin amyloid cardiomyopathy
May 7, 2019Manufacturing and Production, Sales and Marketing FDA, Pfizer, US, Vyndamax, Vyndaqel, pharma
The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …
GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus
April 30, 2019Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma
GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …
Latest content
FibroFind appoints Lee Borthwick as CEO
